1. Home
  2. BCAB vs PBHC Comparison

BCAB vs PBHC Comparison

Compare BCAB & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • PBHC
  • Stock Information
  • Founded
  • BCAB 2007
  • PBHC 1859
  • Country
  • BCAB United States
  • PBHC United States
  • Employees
  • BCAB N/A
  • PBHC N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • PBHC Major Banks
  • Sector
  • BCAB Health Care
  • PBHC Finance
  • Exchange
  • BCAB Nasdaq
  • PBHC Nasdaq
  • Market Cap
  • BCAB 101.0M
  • PBHC 96.0M
  • IPO Year
  • BCAB 2020
  • PBHC N/A
  • Fundamental
  • Price
  • BCAB $1.57
  • PBHC $18.00
  • Analyst Decision
  • BCAB Buy
  • PBHC
  • Analyst Count
  • BCAB 2
  • PBHC 0
  • Target Price
  • BCAB $5.00
  • PBHC N/A
  • AVG Volume (30 Days)
  • BCAB 1.2M
  • PBHC 3.0K
  • Earning Date
  • BCAB 11-07-2024
  • PBHC 10-30-2024
  • Dividend Yield
  • BCAB N/A
  • PBHC 2.22%
  • EPS Growth
  • BCAB N/A
  • PBHC N/A
  • EPS
  • BCAB N/A
  • PBHC N/A
  • Revenue
  • BCAB $11,000,000.00
  • PBHC $35,494,000.00
  • Revenue This Year
  • BCAB N/A
  • PBHC N/A
  • Revenue Next Year
  • BCAB N/A
  • PBHC N/A
  • P/E Ratio
  • BCAB N/A
  • PBHC N/A
  • Revenue Growth
  • BCAB N/A
  • PBHC N/A
  • 52 Week Low
  • BCAB $1.14
  • PBHC $11.41
  • 52 Week High
  • BCAB $4.02
  • PBHC $19.86
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 40.91
  • PBHC 58.11
  • Support Level
  • BCAB $1.33
  • PBHC $17.08
  • Resistance Level
  • BCAB $2.53
  • PBHC $18.49
  • Average True Range (ATR)
  • BCAB 0.26
  • PBHC 0.43
  • MACD
  • BCAB -0.07
  • PBHC 0.02
  • Stochastic Oscillator
  • BCAB 20.08
  • PBHC 73.66

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

Share on Social Networks: